Braveheart Bio, Inc. (BRVE)
NASDAQ · Manufacturing · Pharmaceutical preparations
$20.62−$2.75 (−11.77%) on the dayAs of the close; data may be delayed.
BRVE price, last 12 months
Key stats
- Previous close
- $23.37
- Open
- $23.58
- Day range
- $20.53 – $23.86
- 52-week range
- $20.53 – $32.00
- Volume
- 471.9K
- Avg volume (20 days)
- 561K
- Market cap
- $1.9B
Performance
1W−29.4%
1M−25.7%
3M—
6M—
YTD—
1Y—
Technicals and fundamentals
About Braveheart Bio, Inc.
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.9B